About Us
BioSino Bio-Technology & Science Inc. (hereinafter referred to as BIOSINO) was established in 1988 and listed in Hong Kong in 2006 (stock code: HK8247). It is a high-tech enterprise founded by the Institute of Biophysics, Chinese Academy of Sciences, mainly engaged in the research and development, production, sales and service of in-vitro diagnostic (IVD) products. The history of the company's reagent production can be traced back to the three-link preparation group of the Institute of Biophysics in 1973. The company's development has always been guided by the needs of people's livelihood, actively promoting the development of the national IVD industry, building an independent innovation system combining production, learning, research and application, exploring the "internationalization, groupization, and complexization" business model, and constructing a "systematic, serialized, integrated, and intelligent" four-in-one full industrial chain to enhance core competitiveness and establish a certain influence in the industry. Since the launch of China's enzymatic single and double biochemical reagents, BIOSINO has accumulated a wealth of products over the years, establishing a complete biochemical detection series product platform, expanding immunology, molecular, flow cytometry and other in-vitro diagnostic series products, and is committed to creating a comprehensive clinical diagnosis solution. Currently, it has obtained approximately 270 registration certificates for in-vitro diagnostic reagent products, mainly covering twelve categories of biochemical testing items such as liver function, kidney function, blood lipids, cardiovascular, diabetes, and rheumatism. It is one of the domestic manufacturers with the most complete range of biochemical diagnostic reagent products.
PRODUCTS
Products and Solutions
Committed to creating a comprehensive clinical diagnostic solution
Advantage
BIOSINO Advantages
Technological innovation and in-depth collaboration between industry, academia, and research
A publicly listed IVD R&D and manufacturing company,The company successfully listed on the Growth Enterprise Market of the Hong Kong Stock Exchange in 2006, one of the first IVD companies to be listed in China.
Owns completely independent intellectual property rights and invests approximately 10% of its total annual turnover in R&D.
Has a R&D team composed of numerous doctors and masters, establishing a "Postdoctoral Research Workstation" and jointly establishing a
"Center for In Vitro Diagnostic Engineering Research" with the Institute of Biophysics, Chinese Academy of Sciences,Recognized as the "Beijing Municipal Enterprise Technology Center".
Applied for and led the national "863 Plan" project "Key Biomedical Reagents" as the relying unit.
Has undertaken more than 10 national scientific and technological tasks, including the national "863 Plan," the National Science and Technology Support Plan, and the National High-tech Industry Demonstration Project.
Recognized as an "Innovative Enterprise" in the National Independent Innovation Demonstration Zone.
Since
Company Founded
Production Base
Participation in National-Level Projects
Global Layout
Registration Certificates
NEWS
News
Learn More about the latest News
Company News
Product Recommendations
Exhibition Express